1 – 20 of 29
- show: 20
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Inhibition of oxidized low-density lipoprotein with orticumab inhibits coronary inflammation and reduces residual inflammatory risk in psoriasis: a pilot randomized, double-blind placebo-controlled trial
2024) In Cardiovascular Research(
- Contribution to journal › Article
- 2021
-
Mark
Promoting athero-protective immunity by vaccination with low density lipoprotein-derived antigens
(
- Contribution to journal › Scientific review
-
Mark
Association of Epicardial Fat Volume With the Extent of Coronary Atherosclerosis and Cardiovascular Adverse Events in Asymptomatic Patients With Diabetes
(
- Contribution to journal › Article
- 2014
-
Mark
Vaccine for Atherosclerosis.
(
- Contribution to journal › Scientific review
- 2013
-
Mark
Vaccines against atherosclerosis.
(
- Contribution to journal › Scientific review
- 2012
-
Mark
High levels of IgM against methylglyoxal-modified apolipoprotein B100 is associated with less coronary artery calcification in patients with type 2 diabetes.
(
- Contribution to journal › Article
- 2009
-
Mark
Regulatory T cells and the control of modified lipoprotein autoimmunity-driven atherosclerosis.
(
- Contribution to journal › Article
- 2008
-
Mark
Athero-protective effects of a human apoB-100 related peptide vaccine in apoE-/- mice are modulated by peptide dose and time of initiation of high fat diet
2008) American College of Cardiology 57th Annual Scientific Session In Journal of the American College of Cardiology 51(10, Suppl. 1). p.343-343(
- Contribution to journal › Published meeting abstract
- 2007
-
Mark
Immunization for atherosclerosis
(
- Contribution to journal › Scientific review
-
Mark
Active and passive immunization for atherosclerosis
(
- Contribution to journal › Scientific review
-
Mark
Autoimmune responses against the apo B-100 LDL receptor-binding site protect against arterial accumulation of lipids in LDL receptor deficient mice.
(
- Contribution to journal › Article
-
Mark
Oxidized LDL antibodies in treatment and risk assessment of atherosclerosis and associated cardiovascular disease.
(
- Contribution to journal › Scientific review
-
Mark
Autoantibody against the amino acid sequence 661-680 in apo B-100 is associated with decreased carotid stenosis and cardiovascular events.
2007) In Atherosclerosis(
- Contribution to journal › Article
-
Mark
Immunomodulation of atherosclerosis
2007) p.371-382(
- Chapter in Book/Report/Conference proceeding › Book chapter
-
Mark
Association between IgM against an aldehyde-modified peptide in apolipoprotein B-100 and progression of carotid disease
(
- Contribution to journal › Article
-
Mark
Recombinant antibodies to an oxidized low-density lipoprotein epitope induce rapid regression of atherosclerosis in apobec-1(-/-)/low-density lipoprotein receptor(-/-) mice.
(
- Contribution to journal › Article
- 2006
-
Mark
Oxidized lipoprotein autoimmunity: an emerging drug target in cardiovascular disease
(
- Contribution to journal › Scientific review
-
Mark
Identification of autoantibodies in human plasma recognizing an apoB-100 LDL receptor binding site peptide
(
- Contribution to journal › Article
- 2005
-
Mark
Immunomodulation of Atherosclerosis. Implications for Vaccine Development.
(
- Contribution to journal › Scientific review
-
Mark
Atheroprotective immunization with MDA-modified apo B-100 peptide sequences is associated with activation of Th2 specific antibody expression.
(
- Contribution to journal › Article